semaglutide heart disease Long-Term SELECT Trial: Cuts Cardiovascular Events by 20% beyond Weight Loss FDA Clears Semaglutide For Cardiac

The Wegovy pill joins a lower-dose oral semaglutide that was previously approved for the treatment of diabetes

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al

Combining lipo C and semaglutide together creates a dual-mechanism approach: semaglutide acts as a GLP-1 receptor agonist to reduce appetite and slow gastric emptying, while lipo C provides lipotropic compounds (methionine, inositol, choline) that support hepatic fat metabolism and prevent nutritional deficiencies common during calorie restriction

But no reputable physician should offer you BPC-157 at this time outside of a clinical trial

So black coffee works well for a lot of people, electrolytes, especially sodium can make a massive difference